Clinical Trial Update: A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts [Phase 3]

View source ↗

Summary

A Phase 3 multicenter clinical trial is evaluating the safety and efficacy of specific immunotherapy using modified allergen extracts for allergic rhinitis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Specific Immunotherapy with Modified Allergen Extracts (modified allergen extract)

Snippet

Sponsor: Roxall Medizin | Conditions: Allergic Rhinitis, Allergic Conjunctivitis | Phase 3 | Status: UNKNOWN